ALEMBIC PHARMACEUTICALS

🇮🇳India

Country: 🇮🇳India

Ownership: -

Employees: -

Market Cap: $2.4B

Website

Clinical Trials

Single Dose Crossover Comparative Bioavailability Study of Bupropion Hcl MR Tablet 300mg

Phase 1

Completed

Conditions: Bioequivalence

Interventions: Drug: Bupropion HCl MR tablets 300mg

First Posted Date: 2021-12-16

Last Posted Date: 2022-05-09

Lead Sponsor: Alembic Pharmaceuticals Ltd.

Target Recruit Count: 34

Registration Number: NCT05160090

Locations: 🇨🇦
Algorithme Pharma, Mount Royal, Quebec, Canada
🇨🇦
Algorithme Pharma Inc., Mount-Royal, Quebec, Canada

Comparative Bioavailability Study of Lamotrigine ER Tablets USP 50 mg

Phase 1

Completed

Conditions: Bioequivalence

Interventions: Drug: Lamotrigine ER tablet 50mg

First Posted Date: 2021-12-06

Last Posted Date: 2021-12-07

Lead Sponsor: Alembic Pharmaceuticals Ltd.

Target Recruit Count: 22

Registration Number: NCT05145608

Locations: 🇨🇦
Algorithme Pharma, Mount Royal, Quebec, Canada

Oral Bio-equivalence Study

Phase 1

Completed

Conditions: Safety
Bioequivalence

Interventions: Drug: Fingolimod 0.5 mg capsules- Test drug

First Posted Date: 2021-12-06

Last Posted Date: 2021-12-21

Lead Sponsor: Alembic Pharmaceuticals Ltd.

Target Recruit Count: 26

Registration Number: NCT05145621

Locations: 🇨🇦
Algorithme Pharma Inc., Mount-Royal, Quebec, Canada

Prev
1
Next

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy